TCTR20160314003已完成1 期
Intratympanic Injections of N-acetylcysteine and Dexamethasone for Prevention of Cisplatin-induced Ototoxicity: Double Blind Randomized Clinical Trial
Student Research Committee0 个研究点目标入组 114 人开始时间: 2016年3月14日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 114
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 Years 至 60 Years（—）
- 性别
- All
入选标准
- •first cycle of cisplatin therapy
- •normal tympanogram type A
- •normal microscopic examinations
- •no history of head trauma, brain tumors, severe ear infection, ear surgery, ruptured eardrums, meningoencephalitis, acoustic trauma and cranial radiation
排除标准
- •Patients in the end stages of cancers or taking other ototoxic drugs
研究者
相似试验
进行中（未招募）
1 期
Injection of N-acetylcysteine through the eardrum to reduce hearing loss related to Cisplatin chemotherapy.OtotoxicityMedDRA version: 20.0Level: PTClassification code 10033109Term: OtotoxicitySystem Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2019-004463-44-BECHU Saint Pierre86
招募中
1 期
Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.Ototoxic Hearing LossNCT04291209Sunnybrook Health Sciences Centre80
Enrolling By Invitation
3 期
Intravenous N-acetyl-cysteine (NAC) for Prevention of Post-embolization Syndrome in Hepatocellular CarcinomaTransarterial ChemoembolizationHepatocellular CarcinomaTCTR20150313002Faculty of Medicine, Thammasat University80
招募中
3 期
Preoperative intranenous N-Acetylcysteine for the prevention of renal failure in patients with renal impairment undergoing cardiac surgeryRenal Impairment in cardiac surgeryRenal and Urogenital - Other renal and urogenital disordersCardiovascular - Other surgeryACTRN12606000088549Prince of Wales Hospital200
终止
4 期
Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced OtotoxicityOtotoxic Hearing LossOtotoxic Hearing Loss, BilateralOtotoxicityTinnitusNCT04226456Centre Hospitalier Universitaire Saint Pierre19